상세 보기
자료 필터
자료유형
발행연도
1996 ~ 2043
1996 2043
키워드
언어
전체 482건 중 81번부터 90번까지의 결과를 표시합니다.
2024
Article
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial
- Wainberg, Zev A. ;
- Kang, Yoon-Koo ;
- Lee, Keun-Wook ;
- Qin, Shukui ;
- Yamaguchi, Kensei ;
- ... Oh, Sang Cheul ;
- 외 12명
- 2024-05
- Gastric Cancer
- Springer Verlag
Article
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial
- Kang, Yoon-Koo ;
- Ryu, Min-Hee ;
- Di Bartolomeo, Maria ;
- Chau, Ian ;
- Yoon, Harry ;
- ... Oh, Sang Chul ;
- 외 12명
- 2024-03
- Gastric Cancer
- Springer Verlag
Conference
Outcomes by antibiotic use in participants with advanced biliary tract cancer treated with durvalumab
- Pelzer, Uwe ;
- He, Aiwu R. ;
- Tan, Benjamin ;
- Suksombooncharoen, Thatthan ;
- Takahashi, Hidenori ;
- ... Oh, Sang Cheul ;
- 외 12명
- 2024-02
- 스위스
2023
Conference
Zolbetuximab + CAPOX in 1L claudin-18.2+(CLDN18.2+)/HER22locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.
- Xu, Rui-hua ;
- Shitara, Kohei ;
- Ajani, Jaffer A. ;
- Bang, Yung-Jue ;
- Enzinger, Peter C. ;
- ... Oh, Sang Cheul ;
- 외 14명
- 2023-11-03
- 레위니옹
Conference
Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab plus CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
- Lordick, F. ;
- Shah, M. A. ;
- Shitara, K. ;
- Ajani, J. A. ;
- Bang, Y-J. ;
- ... Oh, S. C. ;
- 외 14명
- 2023-11
- 싱가포르
Conference
Bemarituzumab (bema)+FOLFOX6 as first-line treatment in patients with FGFR2b overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer (G/ GEJC): East Asia subgroup of FIGHT final analysis
- Kang, Y-K. ;
- Qin, S. ;
- Lee, K-W. ;
- Oh, S. C. ;
- Kim, I-H. ;
- 외 10명
- 2023-11
- 싱가포르